SCIENTIFIC BACKGROUND

BGN

Meester-Loeys syndrome describes an X-linked, syndromic form of aortic aneurysms and dissections with skeletal manifestations such as hypertelorism, thoracic deformities, hypermobile joints, contractures and mild skeletal dysplasia.

 

Cardiovascular symptoms include early aortic aneurysms and dissections in male patients, and mild mitral and aortic valve insufficiency. Female carriers may be cardiologically normal, but also have aortic aneurysms and dissections. Skeletal manifestations in male index patients such as chest deformities, hypermobile joints, contractures and striae are sometimes non-specific for various connective tissue diseases. A split uvula, hypertelorism and instability of the cervical spine are also found in patients with Loeys-Dietz syndrome. Thus, there are clinical overlaps with Marfan syndrome and Loeys-Dietz syndrome, but also characteristic differences such as enlargement of the ventricles, macrocephaly, hypertrichosis, gingival hyperplasia, and skeletal dysplasias, such as hip dislocation, formation of flat vertebral bodies, dysplasia of finger and toe phalanges and dysplastic epiphyses of the long bones. The non-cardiovascular manifestations are milder in female carriers.

 

The molecular cause is loss-of-function variants in the BGN gene on chromosome Xq28, which codes for biglycan. Biglycan belongs to the small leucine-rich proteoglycan (SLRP) class I proteins and is involved in the formation and maintenance of the extracellular matrix together with other proteoglycans such as decorin. Biglycan interacts with collagen type I, II, III, VI and elastin and is expressed in bone, skin, heart, lung and arteries. The pathogenic variants described to date in Meester-Loeys syndrome are two genomic deletions of 21 kb and 28 kb that contain large portions of the BGN gene, a nonsense variant, and two missense variants, one of which has been shown to be aberrant splicing and the second predicted to be aberrant splicing. Biglycan deficiency leads to increased TGF-ß signaling within the adventitia of the aortic wall.

 

References

Meester et al. 2017, Genet Med 19:386 / Cho et al. 2016, Am J Hum Genet 98:1243 / Corsi et al. 2002, J Bone Miner Res 17:1180

GENES

BGN
How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more